Caplin Point Laboratories Ltd
NSE:CAPLIPOINT
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Estee Lauder Companies Inc
NYSE:EL
|
Consumer products
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Church & Dwight Co Inc
NYSE:CHD
|
Consumer products
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
American Express Co
NYSE:AXP
|
Financial Services
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Target Corp
NYSE:TGT
|
Retail
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
|
US |
Mueller Industries Inc
NYSE:MLI
|
Machinery
|
|
US |
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
1 198
2 121.7
|
Price Target |
|
We'll email you a reminder when the closing price reaches INR.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Estee Lauder Companies Inc
NYSE:EL
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Church & Dwight Co Inc
NYSE:CHD
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
American Express Co
NYSE:AXP
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Target Corp
NYSE:TGT
|
US | |
Walt Disney Co
NYSE:DIS
|
US | |
Mueller Industries Inc
NYSE:MLI
|
US | |
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one CAPLIPOINT stock under the Base Case scenario is 1 134.85 INR. Compared to the current market price of 1 951.5 INR, Caplin Point Laboratories Ltd is Overvalued by 42%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Caplin Point Laboratories Ltd
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for CAPLIPOINT cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Caplin Point Laboratories Ltd
Balance Sheet Decomposition
Caplin Point Laboratories Ltd
Current Assets | 18.9B |
Cash & Short-Term Investments | 8.4B |
Receivables | 5.4B |
Other Current Assets | 5.1B |
Non-Current Assets | 8.1B |
Long-Term Investments | 1.5B |
PP&E | 5.6B |
Intangibles | 125.2m |
Other Non-Current Assets | 856.5m |
Current Liabilities | 3.3B |
Accounts Payable | 2.1B |
Accrued Liabilities | 103.6m |
Other Current Liabilities | 1.1B |
Non-Current Liabilities | 511.2m |
Long-Term Debt | 9.2m |
Other Non-Current Liabilities | 502m |
Earnings Waterfall
Caplin Point Laboratories Ltd
Revenue
|
17.6B
INR
|
Cost of Revenue
|
-7.3B
INR
|
Gross Profit
|
10.3B
INR
|
Operating Expenses
|
-5.1B
INR
|
Operating Income
|
5.2B
INR
|
Other Expenses
|
-410.7m
INR
|
Net Income
|
4.8B
INR
|
Free Cash Flow Analysis
Caplin Point Laboratories Ltd
INR | |
Free Cash Flow | INR |
Caplin Point Laboratories reported a robust quarter with a 17% revenue increase and a 20% PAT growth. Key highlights include gross margins rising to 59.6% and free cash flow of INR 59 crores. Caplin Steriles displayed notable progress, contributing 16% of total revenue, with expectations to exceed last year's performance. The company's new Caplin One Lab, focusing on high-margin oncology products, is poised to boost future revenue. Additionally, Caplin is expanding into the US market with its front-end distribution model, launching 30+ products within 12-15 months, and making a strategic INR 220-230 crores CapEx investment in its injectable division over the next 2-3 years.
What is Earnings Call?
CAPLIPOINT Profitability Score
Profitability Due Diligence
Caplin Point Laboratories Ltd's profitability score is 69/100. The higher the profitability score, the more profitable the company is.
Score
Caplin Point Laboratories Ltd's profitability score is 69/100. The higher the profitability score, the more profitable the company is.
CAPLIPOINT Solvency Score
Solvency Due Diligence
Caplin Point Laboratories Ltd's solvency score is 99/100. The higher the solvency score, the more solvent the company is.
Score
Caplin Point Laboratories Ltd's solvency score is 99/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
CAPLIPOINT Price Targets Summary
Caplin Point Laboratories Ltd
According to Wall Street analysts, the average 1-year price target for CAPLIPOINT is 1 843.65 INR with a low forecast of 1 550.35 INR and a high forecast of 2 184 INR.
Dividends
Current shareholder yield for CAPLIPOINT is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Ownership
CAPLIPOINT Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Caplin Point Laboratories Ltd. engages in the manufacture and marketing of pharmaceutical products. The company is headquartered in Chennai, Tamil Nadu. The firm is producing, developing and marketing a range of generic formulations and branded products and exporting to overseas markets. Its products include tablets, dry syrups (bottles), soft gels, capsules, suppositories, liquid syrups (bottles), liquid injectables in ampoules and vials, lyophilized vials, prefilled syringes (PFS), emulsion injection in ampoules and vials, ophthalmic droppers, pre-mix bags, topicals, and sachets (liquids and powders). The company also manufactures a range of ointments, creams, gels and lotions. The Company’s principal research and development facilities are located in Tamil Nadu, India. Its principal manufacturing facility is located in Puducherry, India. The Company’s subsidiaries include Caplin Point Far East Limited, Caplin Point (S) PTE Ltd, Caplin Steriles Limited and Caplin Point Laboratories Colombia SAS.
Contact
IPO
Employees
Officers
The intrinsic value of one CAPLIPOINT stock under the Base Case scenario is 1 134.85 INR.
Compared to the current market price of 1 951.5 INR, Caplin Point Laboratories Ltd is Overvalued by 42%.